There are no paradoxes of adherence and drug resistance to HIV antiretroviral therapy - Reply

被引：1

作者：

Bangsberg, DR

Moss, AR

Deeks, SG

机构：

[1] Univ Calif San Francisco, San Francisco Gen Hosp, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA

[2] Univ Calif San Francisco, San Francisco Gen Hosp, AIDS Program, San Francisco, CA USA

[3] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Epidemiol & Biostat, San Francisco, CA USA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2004年 / 54卷 / 03期

关键词：

antiretroviral; resistance; resource-constrained; countries;

D O I：

10.1093/jac/dkh392

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：694 / 695

页数：4

共 11 条

[1]

BANGSBERG D, 2004, ANTIVIR THER, V9, pS179

[2] Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates [J].

Bangsberg, DR ;

Porco, TC ;

Kagay, C ;

Charlebois, ED ;

Deeks, SG ;

Guzman, D ;

Clark, R ;

Moss, A .

JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01) :162-165

[3] High levels of adherence do not prevent accumulation of HIV drug resistance mutations [J].

Bangsberg, DR ;

Charlebois, ED ;

Grant, RM ;

Holodniy, M ;

Deeks, SG ;

Perry, S ;

Conroy, KN ;

Clark, R ;

Guzman, D ;

Zolopa, A ;

Moss, A .

AIDS, 2003, 17 (13) :1925-1932

[4] Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].

Bangsberg, DR ;

Hecht, FM ;

Charlebois, ED ;

Zolopa, AR ;

Holodniy, M ;

Sheiner, L ;

Bamberger, JD ;

Chesney, MA ;

Moss, A .

AIDS, 2000, 14 (04) :357-366

[5] Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].

Bangsberg, DR ;

Perry, S ;

Charlebois, ED ;

Clark, RA ;

Roberston, M ;

Zolopa, AR ;

Moss, A .

AIDS, 2001, 15 (09) :1181-1183

[6] Drug resistance in patients experiencing early virological failure under a triple combination including indinavir [J].

Gallego, O ;

de Mendoza, C ;

Pérez-Elías, MJ ;

Guardiola, JM ;

Pedreira, J ;

Dalmau, D ;

Gónzalez, J ;

Moreno, A ;

Arribas, JR ;

Rubio, A ;

García-Arata, I ;

Leal, M ;

Domingo, P ;

Soriano, V .

AIDS, 2001, 15 (13) :1701-1706

[7] Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up [J].

Hogg, RS ;

Heath, K ;

Bangsberg, D ;

Yip, B ;

Press, N ;

O'Shaughnessy, MV ;

Montaner, JSG .

AIDS, 2002, 16 (07) :1051-1058

[8]

HOWARD A, 2001, 1 INT AIDS SOC C HIV

[9]

KING M, 2003, ANTIVIR THER, V8, pS118

[10]

Miller L, 2003, ANTIVIR THER, V8, pU142

← 1 2 →